14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AVTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Avalo Therapeutics, Inc. stock price on Friday which ended trading at $14.36
(Updated on May 03, 2024)

Buy or Hold candidate since Apr 01, 2024 Loss -19.78% PDF

The Avalo Therapeutics, Inc. stock price fell by -6.69% on the last day (Friday, 3rd May 2024) from $15.39 to $14.36. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 21.67% from a day low at $13.15 to a day high of $16.00. The price has risen in 7 of the last 10 days and is up by 23.47% over the past 2 weeks. Volume has increased on the last day by 38 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 92 thousand shares were bought and sold for approximately $1.31 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 115.58% during the next 3 months and, with a 90% probability hold a price between $23.69 and $59.82 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AVTX Signals & Forecast

The Avalo Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $15.81. On a fall, the stock will find some support from the long-term average at approximately $12.52. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -33.98%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Avalo Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Avalo Therapeutics, Inc. stock

Avalo Therapeutics, Inc. finds support from accumulated volume at $14.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.85 between high and low, or 21.67%. For the last week, the stock has had daily average volatility of 13.62%.

Our recommended stop-loss: $13.63 (-5.06%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 25 days ago.)

Trading Expectations (AVTX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Avalo Therapeutics, Inc. to open at $14.50, and during the day (based on 14 day Average True Range), to move between $12.12 and $16.60, which gives a possible trading interval of +/-$2.24 (+/-15.61%) up or down from last closing price. If Avalo Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 31.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $14.19 (1.18%) than the resistance at $15.16 (5.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Avalo Therapeutics, Inc. stock A Buy?

Avalo Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.149 Hold/Accumulate Downgraded

Predicted Opening Price for Avalo Therapeutics, Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$14.50 ( 1.00%) $14.36

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AVTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.35 20.84 %
R2 16.26 13.26 %
R1 15.59 8.58 %
Current price: 14.36
Support S1 13.41 -6.58 %
S2 12.74 -11.27 %
S3 11.65 -18.85 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 17.90 24.65 %
R2 16.30 13.51 %
R1 15.16 5.57 %
Current price 14.36
Support S1 14.19 -1.18%
S2 13.62 -5.15%
S3 12.01 -16.36%

FAQ

What is the symbol for Avalo Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Avalo Therapeutics, Inc. is AVTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Avalo Therapeutics, Inc. Stock?
Avalo Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Avalo Therapeutics, Inc. Stock?
Avalo Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Avalo Therapeutics, Inc. Stock.

What's the current price of Avalo Therapeutics, Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Avalo Therapeutics, Inc. (AVTX) share was $14.36.

What is the 52-week high and low for Avalo Therapeutics, Inc. Stock?
The 52-week high for Avalo Therapeutics, Inc. Stock is $34.46 and the 52-week low is $0.0333.

What is the market capitalization of Avalo Therapeutics, Inc. Stock?
As of the May 03, 2024, the market capitalization of Avalo Therapeutics, Inc. is 14.85M.

When is the next earnings date for Avalo Therapeutics, Inc.?
The upcoming earnings date for Avalo Therapeutics, Inc. is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Avalo Therapeutics, Inc.

Avalo Therapeutics. Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe... AVTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT